Of the 52 patients initially enrolled, two patients from the experimental group were excluded because they did not enter
information on the website for more than four weeks. Although these two patients were assessed in the post-test for ethical consideration, their test results were not used in data analysis. Also, two patients were excluded from the control group as a result of unwillingness to complete the study (attrition rate: 7Æ7). Therefore, the data analysis was performed on 48 patients. Slightly more than half of the participants were women (57%). The age range of the patients was 18–39 years, and mean age was 23Æ35 years. Almost all participants (97%) had type 1 diabetes. The results for different metabolic control indicators are shown in Table 3. In the experimental group, mean average HbA1C decreased significantly from 9Æ10% at the beginning of the intervention to 7Æ07% after twelve weeks (p < 0Æ001). Mean
LDL decreased significantly from 103Æ04 mg/dl at the beginning of the intervention to 94Æ83 mg/dl after twelve weeks
(p < 0Æ04). Mean HDL increased significantly from 40 mg/dl at the beginning of the intervention to 45Æ58 mg/dl after twelve weeks (p < 0Æ029). In the control group, HDL increased significantly, but there were no significant changes in the other variables. According to t-tests for independent samples, the mean changes in indicators differed significantly
between groups for HbA1C and LDL